Detection of growth hormone abuse in sport.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

To develop a test for GH abuse in sport.

Who Took Part

By PubMed's age tags, the people studied were teenagers and adults, both men and women.

A double blind placebo controlled study of one month's GH administration to 102 healthy non-competing but trained subjects.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

Blinding on both sides kept the participants and researchers unaware of who received Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.

Blood samples were also taken from 813 elite athletes both in and out of competition.

What Was Measured

PubMed files the paper under topics including Biomarkers, Doping in Sports, Growth Hormone, Insulin-Like Growth Factor I, Peptide Fragments, Procollagen and Substance-Related Disorders.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2007 (Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society), a journal based in Scotland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.